diaPatch™
A non-invasive cervical cancer diagnostic patch
Our flagship product, diaPatch™ is a wearable diagnostic patch combining microneedles-mediated interstitial fluid sampling with a molecular assay to support adjunctive cervical risk stratification and triage.
Human-centered designed for the clinical decision window following abnormal Pap smear screening before a colposcopy follow-up.
Higher Specificity
Pap smear testing is highly specific, but sensitivity can be limited (often cited ~55% for high-grade disease), which can delay detection and lead to additional follow-up, often requiring colposcopy, an invasive and resource-intensive step.
​
While adjunct biomarkers do exist for triage (e.g., p16/Ki-67 dual-stain cytology, which is FDA-approved and incorporated into management guidance), there are still no widely adopted non-invasive, point-of-care molecular options that reliably streamlines the colposcopy pathway.
Faster
Designed for same-visit triage after abnormal screening, reducing delays that often lead to prolonged colposcopy pathways.
Higher Sensitivity
Designed to improve access and operational efficiency for cancer centers, hospitals, clinics, and physician offices, reducing delays, repeat visits, and care pathway friction.
Non-Invasive
Applying diaPatch™ is as simple as placing a wearable patch on the external lower pelvic region. It is designed to reduce reliance on invasive diagnostic steps and repeat visits that often lead to colposcopy
The Patient Experience
1. A healthcare professional places the patch on the patient's external low abdominal pelvic region
2. Patient waits 30 min for fluid to be analyzed once sampled
3. Patch is removed
4. Results are given during the same clinical visit
5. The companion app, the ELLEApp™ supports result delivery and follow-up reminders.
Unsettling Pap Smear Facts
26M
Pap smears Performed Annually in the US
45%
True Positives Are Missed
64%
Women Experience Anxiety Before the Procedure
2wks
To Receive Test Results
Our Milestones
Strong IP Moat
Currently Fundraising
NSF I-Corps Program
Membership and Accelerators
